Biotech

Latest Articles

Cassava pays $40M over purportedly misleading Alzheimer's upgrade

.Cassava Sciences has accepted pay out $40 thousand to resolve an inspection right into claims it ma...

Merck bags choices on Evaxion's AI-designed injection candidates

.Merck &amp Co. has gotten alternatives on pair of Evaxion Biotech injection candidates, paying for ...

Enanta's RSV antiviral crushes popular lots in difficulty study

.Enanta Pharmaceuticals has connected its own respiratory system syncytial virus (RSV) antiviral to ...

Biogen containers SAGE-324 collaboration after essential tremor fall short

.Biogen has actually conducted the final rites to its collaboration along with Sage Therapies on SAG...

AbbVie Parkinson's medication from $8.7 B Cerevel purchase scores

.On the very same day that some Parkinson's disease medications are being brought into question, Abb...

Arch shuts $3B-plus fund to foster biopharma startups

.On the heels of a $3 billion fund from Bain Financing Lifestyle Sciences, Arch Venture Allies is pr...

Orion to use Aitia's 'electronic twins' to locate brand-new cancer medications

.Finnish biotech Orion has actually spied prospective in Aitia's "digital twin" technician to create...

Windtree's shock med brings up high blood pressure in most recent period 2 gain

.While Windtree Therapies has strained to grow the monetary roots required to make it through, a per...

2 cancer biotechs combine, making international footprint

.OncoC4 is actually taking AcroImmune-- and its in-house medical manufacturing capacities-- under it...

Amgen reports very first phase 3 gain for $400M eczema drug

.Amgen has shared (PDF) the very first period 3 records on its own $400 thousand dermatitis medicine...

Biogen, UCB document phase 3 lupus succeed after failing earlier trial

.Biogen and also UCB's bank on advancing into period 3 on the back of a failed study tries to have p...

Aptadir really hopes brand new RNA preventions may reverse difficult cancers cells

.Italian biotech Aptadir Rehabs has launched with the pledge that its own pipeline of preclinical RN...

Wave surfs DMD success to regulatory authorities' doors, sending out stock up

.Wave Lifestyle Sciences has actually met its own target in a Duchenne muscle dystrophy (DMD) resear...

Sanofi tweezes brand-new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma crease, ta...

Achilles trickles tissue treatment plan, prepares for discharges after overlooking 'commercial stability' objectives

.Achilles Rehabs has shreded its tactic. The English biotech is actually knocking off on its own cli...

Aligos trumpets period 2 MASH win, lowering liver fat approximately 46%

.Aligos Therapies is actually advertising a midstage succeed in metabolic-dysfunction affiliated ste...

Basilea scores $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's work creating new antifungals has actually acquired a notable increase comi...

Capricor sells Europe legal rights to late-stage DMD therapy for $35M

.Possessing currently scooped up the USA civil rights to Capricor Rehabs' late-stage Duchenne muscle...

FDA junks adcomm for Applied's unusual illness drug

.After pushing the choice date for Applied Therapies' metabolic ailment medication govorestat, the F...

Novo inks $600M NanoVation deal to analyze hereditary medicines ex-liver

.Novo Nordisk is actually continuing its push into genetic medications, accepting to compensate Nano...